Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 54, 2024 - Issue 2
40
Views
0
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Safflower yellow for injection enhances anti-coagulation of warfarin in rats: implications in pharmacodynamics and pharmacokinetics

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 75-82 | Received 04 Dec 2023, Accepted 02 Mar 2024, Published online: 13 Mar 2024

References

  • Amaraneni A, Chippa V, Rettew AC. 2023. Anticoagulation Safety. Treasure Island (FL): statPearls Publishing.
  • Chen Y, Li MF, Wen JY, Pan XQ, Deng ZX, Chen JR, Chen GR, Yu L, Tang YL, Li GM, et al. 2022. Pharmacological activities of safflower yellow and its clinical applications. Evid Based Complement Alternat Med. 2022:2108557. doi: 10.1155/2022/2108557.
  • Christiane FC, Tania AA, Isabela H. 2019. Drug interactions and adverse events in a cohort of warfarin users attending public health clinics. Int J Cardiovasc Sci. 32(2):110–117.
  • De Athayde Soares R, Matielo MF, Brochado Neto FC, Nogueira MP, Almeida RD, Sacilotto R. 2019. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin. Surgery. 166(6):1076–1083. doi: 10.1016/j.surg.2019.05.030.
  • Drew RJ, Grover PM. 2011. Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know. Expert Opin Drug Metab Toxicol. 7(7):857–874.
  • Fu S, Zhou Q, Gao Y, Yang YJ, Chen HZ, Yuan LJ, Li ZN, Chen Q. 2022. Antioxidant and anti-inflammatory properties of hydroxyl safflower yellow a in diabetic nephropathy: a meta-analysis of randomized controlled trials. Front Pharmacol. 13:929169. doi: 10.3389/fphar.2022.929169.
  • Hou LQ, Wang YY. 2022. 我院2020年住院患者中药注射剂使用情况 [Analysis on the use of traditional Chinese medicine injections among inpatients in a hospital in 2020]. Chin J Pharm Econ. 17(4):117–128. Chinese.
  • Huang AM, Zhang PZ, Qi J. 2019. 注射用红花黄色素对髋骨骨折患者下肢肿胀及生命质量的影响 [Effects of Safflower Yellow pigment for injection on lower limb swelling and quality of life in patients with hip fracture]. World Chin Med. 14(4):954–957. Chinese.
  • Huang YS, Lu M, Han QH, Chang LS. 2015. 注射用红花黄色素治疗稳定型劳累性心绞痛的有效性和安全性的多中心开放性临床研究 [An open and multi-center research a clinical efficiency and safety of Safflor Yellow injection in the patients with stable angina pectoris]. J Clin Cardiovasc Dis. 31(12):1306–1311. Chinese.
  • Huber GA, Priest SM, Geisbuhler TP. 2017. Cardioprotective effect of Hydroxysafflor Yellow A via the cardiac permeability transition pore. Planta Med. 84(08):507–518.
  • Leite PM, Martins MAP, Carvalho MDG, Castilho RO. 2021. Mechanisms and interactions in concomitant use of herbs and warfarin therapy: an updated review. Biomed Pharmacother. 143:112103. doi: 10.1016/j.biopha.2021.112103.
  • Li LM, Fu JH, Guo H, Han X, Li L, Xin GJ, Zhao YW, Zhang Q, Zheng QS, Liu JX. 2019. [Protective effect of safflower yellow injection against rat MIRI by TLR-NF-κB inflammatory pathway]. Zhongguo Zhong Yao Za Zhi. 44(12):2566–2571. Chinese.
  • Li Y, Lin Y, Shi ZX, Hu YX, Shao TH, Li MY, Zhu JW, Sun LZ, Chang F. 2021. Safflower yellow pigment and Sanqi Panax notoginseng in the treatment of acute cerebral infarction: a systematic review, meta-analysis, and cost-effectiveness analysis. Ann Transl Med. 9(18):1407–1407. doi: 10.21037/atm-21-782.
  • Liu L, Duan JA, Tang Y, Guo J, Yang N, Ma H, Shi X. 2012. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. J Ethnopharmacol. 139(2):381–387. doi: 10.1016/j.jep.2011.11.016.
  • Lockhart Peter B. 2016. AAOM clinical practice statement: subject: management of patients on warfarin therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 122(6):702–704.
  • Lu PH, Kuo CY, Chan CC, Wang LK, Chen ML, Tzeng IS, Tsai FM. 2021. Safflower extract inhibits ADP-induced human platelet aggregation. Plants. 10(6):1192. doi: 10.3390/plants10061192.
  • Peng SX, Wei C, Lei JY, Zhang T, Ding YB. 2023. [Network Meta-analysis of Chinese medicine injections for activating blood and resolving stasis in adjuvant treatment of acute ischemic stroke]. Zhongguo Zhong Yao Za Zhi. 48(15):4215–4230. Chinese.
  • Pourgholi L, Goodarzynejad H, Mandegary A, Ziaee S, Talasaz AH, Jalali A, Boroumand M. 2016. Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR). Toxicol Appl Pharmacol. 309:37–43. doi: 10.1016/j.taap.2016.08.026.
  • Qiao Y, Shi Y, Wu C, Hou X, Pan X, Deng Z, Wang S. 2021. Rapid screening and identification of anticoagulation component from carthami flos by two-dimensional thrombin affinity chromatography combined with HPLC-MS/MS. J Sep Sci. 44(16):3061–3069. doi: 10.1002/jssc.202100092.
  • Tan CSS, Lee SWH. 2021. Warfarin and food, herbal or dietary supplement interactions: a systematic review. Br J Clin Pharmacol. 87(2):352–374. doi: 10.1111/bcp.14404.
  • Wang LW, Cui XY, He JF, Duan S, Liu CR, Shan CB, Wang Y, Ma CM. 2021. Hydroxysafflor yellows alleviate thrombosis and acetaminophen-induced toxicity in vivo by enhancing blood circulation and poison excretion. Phytomedicine. 87:153579. doi: 10.1016/j.phymed.2021.153579.
  • Wang W, Cao L, Ren P, Zhu BB, Liu K. 2023. [Network Meta-analysis of Chinese medicine injection combined with conventional Western medicine in the treatment of stable angina pectoris]. Zhongguo Zhong Yao Za Zhi. 48(3):1652–1663. Chinese.
  • Wang YL, Zhang Q, Yin SJ, Cai L, Yang YX, Liu WJ, Hu YJ, Chen H, Yang FQ. 2019. Screening of blood-activating active components from Danshen-Honghua herbal pair by spectrum-effect relationship analysis. Phytomedicine. 54:149–158. doi: 10.1016/j.phymed.2018.09.176.
  • Wei W, Wu XM, Li YJ. 2010. Experimental Methodology of Pharmacology. fourth ed. Beijing (BJ): People’s Medical Publishing House. p. 70–71.
  • Wen MS, Lee MT. 2013. Warfarin pharmacogenetics: new life for an old drug. Acta Cardiol Sin. 29(3):235–242.
  • Xu RA, Xu ZS, Ge RS. 2013. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats. J Ethnopharmacol. 151(3):1141–1146. doi: 10.1016/j.jep.2013.12.025.
  • Xuan JW, Huang M, Lu YJ, Tao LB. 2018. Economic evaluation of safflower yellow injection for the treatment of patients with stable angina pectoris in China: a cost-effectiveness analysis. J Altern Complement Med. 24(6):564–569. doi: 10.1089/acm.2017.0284.
  • Xue XY, Deng Y, Wang J, Zhou MT, Li L, Wang C, Peng C, Li YX. 2021. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. Phytomedicine. 91:153694. doi: 10.1016/j.phymed.2021.153694.
  • Yan TC, Xiang LA, Xi MZ, Kei SK. 2015. Interaction between warfarin and Chinese herbal medicines. Singapore Med J. 56(1):11–18. doi: 10.11622/smedj.2015004.
  • Yang XW, Li YH, Zhang H, Zhao YF, Ding ZB, Yu JZ, Liu CY, Liu JC, Jiang WJ, Feng QJ, et al. 2016. Safflower yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int J Immunopathol Pharmacol. 29(1):54–64. doi: 10.1177/0394632015617065.
  • Yao D, Wang Z, Miao L, Wang LY. 2016. Effects of extracts and isolated compounds from safflower on some indexes of promoting blood circulation and regulating menstruation. J Ethnopharmacol. 191:264–272. doi: 10.1016/j.jep.2016.06.009.
  • Yu L, Jin Z, Li MC, Liu HF, Tao J, Chuan X, Wang LW, Zhang QJ. 2022. Protective potential of hydroxysafflor yellow A in cerebral ischemia and reperfusion injury: an overview of evidence from experimental studies. Front Pharmacol. 13:1063035. doi: 10.3389/fphar.2022.1063035.
  • Zhang DQ, Mu YP, Xu Y, Chen JM, Liu P, Liu W. 2022. Research progress in Chinese medicine preparations for promoting blood circulation and removing blood stasis for cirrhotic patients with portal vein thrombosis following splenectomy. Chin J Integr Med. 28(9):855–863. doi: 10.1007/s11655-020-3271-8.
  • Zhang F, Huang J, He RJ, Wang L, Huo PC, Guan XQ, Fang SQ, Xiang YW, Jia SN, Ge GB. 2020. Herb-drug interaction between Styrax and warfarin: molecular basis and mechanism. Phytomedicine. 77:153287. doi: 10.1016/j.phymed.2020.153287.
  • Zhang LL, Tian K, Tang ZH, Chen XJ, Bian ZX, Wang YT, Lu JJ. 2016. Phytochemistry and pharmacology of Carthamus Tinctorius L. Am J Chin Med. 44(2):197–226. doi: 10.1142/S0192415X16500130.
  • Zhang MZ, Ding BH, Lin Q. 2021. 急性心肌梗死中医临床诊疗指南 [Clinical practice guideline of Chinese medicine for acute myocardial infarction]. Chin J Tradit Chin Med. 36(7):4119–4127. Chinese.
  • Zhang WL, Jiang MT, Liu Y, Chen JY, Zhou YX, Liu GF. 2020. 冠心宁注射液对大鼠体内华法林抗凝作用的影响及机制[Effect and mechanism of Guanxinning injection on anticoagulation of warfarin in rats in vivo]. Prac Pharm Clin Rem. 23(7):577–583. Chinese.
  • Zhang YY, Kang Y, Ni Y, Cheng YC, Hao XL. 2022. 基于 CiteSpace 的注射用红花黄色素研究现状可视化分析 [Visual analysis of research status of Safflower Yellow for injection based on CiteSpace]. Chin Med Pharm. 12(3):67–70. Chinese.
  • Zhao F, Wang P, Jiao YY, Zhang XX, Chen DQ, Xu HY. 2020. Hydroxysafflflor Yellow A: a systematical review on botanical resources, physicochemical properties, drug delivery system, pharmacokinetics, and pharmacological effects. Front Pharmacol. 11:579332. doi: 10.3389/fphar.2020.579332.
  • Zhuang W, Liu SL, Zhao XS, Sun N, He T, Wang YL, Jia BB, Lin XL, Chu YQ, Xi SY. 2021. Interaction between Chinese medicine and warfarin: clinical and research update. Front Pharmacol. 12:751107. doi: 10.3389/fphar.2021.751107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.